Docket Number:11A-940826
Inventor:Andrew H.-J. Wang, Kai-Fa Huang
IP Status:Issued TWI310052, US 7,572,614B2
Abstract:
We provide, for the first time, a structural basis for the rational design of potent inhibitors against glutaminyl cyclase-associated human disorders, such as Alzheimer's disease, osteoporosis, and rheumatoid arthritis.
Fields of Application:
Structural-based drug desing for the treatment of glutaminyl cyclase-related human diseases.
Advantages when compared to the existing technologies:
We provide the first experimentally three-dimensional structure of human glutaminyl cyclase.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
